Cancer: A medical emergency

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1054-1059

  Harless, William ^a   Qiu, Yang ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; GROWTH FACTOR; NAVELBINE;

ACCURACY; ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CELL CYCLE; CLINICAL PRACTICE; DATA ANALYSIS; DRUG EFFICACY; DYING; EMERGENCY; ENVIRONMENTAL FACTOR; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTUITION; MATHEMATICAL MODEL; METASTASIS; MICROMETASTASIS; MOLECULAR CLONING; PRIORITY JOURNAL; TIME; TUMOR CELL; TUMOR GROWTH; WOUND HEALING;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DEVELOPED COUNTRIES; EMERGENCIES; HUMANS; KINETICS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; WOUND HEALING;

EID: 33748076149     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.032     Document Type: Article

References (37)

1. Yancik R. Population aging and cancer: a cross-national concern. Cancer J 11 (2005) 437-441
2. Chang S., et al. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 22 (2004) 3524-3530
3. Salomaa E., Sallinen S., Hiekkanen H., and Lippo K. Delays in the diagnosis and treatment of lung cancer. Chest 128 (2005) 2282-2288
4. Simunovic M., et al. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centers in Ontario. CMAJ 165 (2001) 421-425
5. Rayson D., Chiasson D., and Dewar R. Elapsed time from breast cancer detection to first adjuvant therapy in a Canadian province, 1999-2000. CMAJ (2004) 170
6. Bogenrieder T., and Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22 (2003) 6524-6536
7. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg 89 (2002) 1505-1515
8. Laso C.C., et al. Prognostic value of micrometastases in esophageal and colorectal carcinoma. Hepatogastroenterology 58 (2004) 964-967
9. Sakorafas G.H., Geraghty J., and Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 48 (2004) 807-816
10. Perez-Cardona J.H., Ordonez N.G., and Fossella F.V. Lymph node micrometastasis in non small cell lung cancer: clinical applications. Clin Lung Cancer 2 (2000) 116-120
11. Narayansingh G.V., et al. The prognostic significance of micrometastases in node negative squamous cell carcinoma of the vulva. Br J Cancer 92 (2005) 222-224
12. Winston T., et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 352 (2005) 2589-2597
13. O'Connell M., et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high risk colon cancer. J Clin Oncol 16 (1998) 295-300
14. Wolmark N., et al. A phase III trial comparing FULV to FULV and oxaliplatin in stage II or III carcinoma of the colon: results of NSABP protocol C-07. J Clin Oncol 23 (2005) 247
15. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet 365 (2005) 1687-1717
16. Baum M., Demicheli R., Hrushesky W., and Resky M. Does surgery unfavourably perturb the natural history of early breast cancer by accelerating the appearance of distant metastases?. Eur J Cancer 41 (2005) 508-515
17. Fisher B., et al. Presence of a growth stimulating factor in serum following primary tumor removal in mice. Cancer Res 49 (1989) 1996-2001
18. Stalder M., Birsan T., Hausen B., Borie D., and Morris R.E. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy. Transpl Int 10 (2005) 1158-1165
19. Hensler T., et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65 (1997) 2283-2291
20. Pages F., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353 (2005) 2654-2666
21. Ochsenbein A.F., et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA 96 (1999) 2233-2238
22. Norton L.A. Gompertzian model of human breast cancer growth. Cancer Res 48 (1988) 7067
23. Gunduz N., Fisher B., and Saffer E.A. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39 (1979) 3861-3865
24. Carlson J.A. Tumor doubling time of cutaneous melanoma and its metastasis. Am J Dermatopathol 25 (2003) 291-299
25. Spratt J.S., Meyer J., and Spratt J.A. Rates of growth of human neoplasms. J Surg Oncol 61 (1996) 68-83
26. Devita V.T., and Schein P.S. The use of drugs in combination for the treatment of cancer: rationale and results. N Engl J Med 288 (1973) 998-1006
27. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11 (2001) 97-104
28. Sugimoto T., et al. Growth factor mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small cell lung cancer. Oncol Rep 14 (2005) 823-830
29. Kaplan R., et al. VEGFR-1 positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
30. Gasinska A., et al. Lewis lung carcinoma and two transplantable sarcomas in mice as experimental therapy models: biological characteristics and cell population kinetics. Folia Histochem Cytobiol 35 (1997) 165-173
31. El Sharouni S., Kal H., and Battermann J. Accelerated regrowth of non-small cell lung tumours after induction chemotherapy. Br J Cancer 89 (2003) 2184-2189
32. Wick M., et al. Antigenic cancer cells grow progressively in immune hosts without evidence for T-cell exhaustion or systemic anergy. J Exp Med 186 (1997) 229-238
33. Tsai C., et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 270 (1995) 1197-1199
34. Tsai C., et al. Effectiveness of postinoculation (R)-9-(2-phosphoylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIV infection depends critically on timing of initiation and duration of treatment. J Virol 72 (1998) 4265-4273
35. Gerberding J. Occupational exposure to HIV in health care settings. N Engl J Med 348 (2003) 826-833
36. Romano F., et al. Biological, histological, and clinical impact of preoperative Il-2 administration in radically operable gastric cancer patients. J Surg Oncol 88 (2004) 240-247
37. Yang H., Dithmar S., and Grossniklaus H. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic natural killer cells. Invest Ophthalmol Vis Sci 45 (2004) 2056-2064